[Heparin cofactor II studies in thrombophilic patients]
- PMID: 2179813
[Heparin cofactor II studies in thrombophilic patients]
Abstract
The plasma concentration of heparin cofactor II was measured by "rocket" immunoelectrophoresis in healthy volunteers, patients taking Syncumar and thrombophiliacs. The values in healthy volunteers averaged 99% (+/- 16.5). In the group of Syncumar treated patients 100% (+/- 10.5) was measured. This did not differ from the control group. The average of heparin cofactor II level in thrombophiliacs was 92.5% (+/- 23). In this group three patients had low heparin cofactor II levels. In one case this was due to intestinal protein loss. In the two other cases the role of heparin cofactor II is uncertain in the pathogenesis of thrombophilia.
Similar articles
-
Further investigations on antithrombin III in the plasmas of patients with the abnormality of antithrombin III Budapest.Thromb Diath Haemorrh. 1975 Jun 30;33(3):564-72. Thromb Diath Haemorrh. 1975. PMID: 1154312
-
Prevalence of heparin cofactor II deficiency in patients with a history of venous thrombosis.Pol J Pharmacol. 1996 Jan-Feb;48(1):109-11. Pol J Pharmacol. 1996. PMID: 9112638
-
Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto.Thromb Haemost. 1989 Feb 28;61(1):20-4. Thromb Haemost. 1989. PMID: 2749590
-
Blood viscosity and thrombosis: clinical considerations.Prog Hemost Thromb. 1982;6:179-201. Prog Hemost Thromb. 1982. PMID: 6762612 Review.
-
[Etiological analysis of thrombophilia].Rinsho Byori. 1997 Nov;45(11):1025-30. Rinsho Byori. 1997. PMID: 9396341 Review. Japanese.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical